论文部分内容阅读
Objective: To determine the predictive ability of biomarkers for responses to neoadjuvant endocrine therapy (NET) in postmenopausal breast cancer. Methods: Consecutive 160 postmenopausal women with T 1-3 N 0-1 M 0 hormone receptor (HR)-positive invasive b